Outset Medical, Inc. — Director's Dealing 2021

Mar 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Outset Medical, Inc. (OM)
CIK: 0001484612
Period of Report: 2021-03-15

Reporting Person: Trigg Leslie (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-15	Common Stock	A	29137	—	Acquired	192383	Direct
2021-03-15	Common Stock	A	58275	—	Acquired	250658	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-15	Stock Option (Right to Buy)	$25.89	A	57937	Acquired	2031-03-14	Common Stock (57937)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8770	Indirect

Footnotes

F1: These shares of common stock of the Issuer ("Shares") are held directly by The Trigg Family Trust U/A DTD 01/01/2002, for which the reporting person and her spouse serve as trustees.

F2: Represents restricted stock units ("RSU") granted to the reporting person on March 15, 2021. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 25% on March 15, 2022, then quarterly over three years on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

F3: Includes 1,666 shares acquired under the Outset Medical Inc. Employee Stock Purchase Plan on February 28, 2021.

F4: Represents performance stock units ("PSU") granted to the reporting person on March 15, 2021. Each PSU represents a contingent right to receive one share of common stock. These PSUs shall vest (i) 50% on the last day of any period of 30 consecutive trading days during which the closing price is greater than $75.00 per share on each trading day during such period, subject to the reporting person's continued employment through the applicable vesting date and (ii) 50% shall vest on the last day of any period of 30 consecutive trading days during which the closing price is greater than $90.00 per share on each trading day during such period, subject to the reporting person's continued employment through the applicable vesting date.

F5: This option vests 25% on March 15, 2022, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.